Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyaluronan Receptors | 13 | 2021 | 142 | 4.370 |
Why?
|
| Hyaluronic Acid | 19 | 2017 | 206 | 3.770 |
Why?
|
| Colonic Neoplasms | 9 | 2021 | 299 | 1.900 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2017 | 126 | 1.520 |
Why?
|
| Cyclooxygenase 2 | 5 | 2013 | 160 | 1.180 |
Why?
|
| Myofibroblasts | 2 | 2017 | 60 | 1.100 |
Why?
|
| Signal Transduction | 15 | 2021 | 2689 | 1.060 |
Why?
|
| Pulmonary Fibrosis | 2 | 2017 | 157 | 0.910 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2021 | 3 | 0.760 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 84 | 0.740 |
Why?
|
| Autocrine Communication | 2 | 2017 | 37 | 0.690 |
Why?
|
| Proto-Oncogene Proteins c-met | 3 | 2016 | 33 | 0.680 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2021 | 332 | 0.620 |
Why?
|
| Neoplasms | 5 | 2016 | 1667 | 0.620 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 468 | 0.590 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2016 | 63 | 0.590 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2017 | 42 | 0.570 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2008 | 100 | 0.560 |
Why?
|
| Antineoplastic Agents | 5 | 2016 | 1070 | 0.560 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 80 | 0.560 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2013 | 9 | 0.560 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2013 | 14 | 0.550 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 247 | 0.550 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 147 | 0.550 |
Why?
|
| Genetic Therapy | 2 | 2009 | 291 | 0.550 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 66 | 0.540 |
Why?
|
| Epithelial Cells | 3 | 2008 | 431 | 0.540 |
Why?
|
| Cells | 1 | 2015 | 7 | 0.530 |
Why?
|
| Cell Physiological Phenomena | 1 | 2015 | 19 | 0.520 |
Why?
|
| Lung | 2 | 2017 | 849 | 0.490 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 493 | 0.470 |
Why?
|
| Receptor, ErbB-2 | 5 | 2009 | 129 | 0.460 |
Why?
|
| Hydrazines | 1 | 2013 | 23 | 0.440 |
Why?
|
| Cyclohexanones | 1 | 2013 | 9 | 0.440 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 46 | 0.430 |
Why?
|
| Oligosaccharides | 3 | 2008 | 26 | 0.430 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2013 | 110 | 0.420 |
Why?
|
| Cell Adhesion Molecules | 3 | 2019 | 199 | 0.410 |
Why?
|
| Cell Line, Tumor | 9 | 2013 | 1851 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2014 | 223 | 0.380 |
Why?
|
| Hyaluronan Synthases | 4 | 2017 | 21 | 0.370 |
Why?
|
| RNA Interference | 2 | 2010 | 266 | 0.360 |
Why?
|
| Receptors, Androgen | 1 | 2010 | 34 | 0.350 |
Why?
|
| RNA, Small Interfering | 4 | 2008 | 434 | 0.350 |
Why?
|
| Heart Valves | 3 | 2019 | 171 | 0.350 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1293 | 0.340 |
Why?
|
| Cell Proliferation | 6 | 2014 | 1174 | 0.330 |
Why?
|
| Nanoparticles | 2 | 2009 | 254 | 0.320 |
Why?
|
| Transferrin | 1 | 2009 | 94 | 0.310 |
Why?
|
| RNA | 1 | 2009 | 171 | 0.310 |
Why?
|
| Adenoma | 1 | 2009 | 132 | 0.300 |
Why?
|
| Carcinoma | 2 | 2006 | 215 | 0.300 |
Why?
|
| Intestines | 1 | 2008 | 114 | 0.290 |
Why?
|
| Cell Survival | 7 | 2019 | 901 | 0.290 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 219 | 0.280 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1034 | 0.270 |
Why?
|
| Antigens, Neoplasm | 2 | 2004 | 132 | 0.270 |
Why?
|
| Mice | 9 | 2019 | 8474 | 0.260 |
Why?
|
| Antigens, CD | 2 | 2004 | 230 | 0.260 |
Why?
|
| Humans | 24 | 2021 | 68618 | 0.260 |
Why?
|
| Animals | 13 | 2019 | 20881 | 0.250 |
Why?
|
| Genes, MDR | 1 | 2005 | 9 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 756 | 0.230 |
Why?
|
| Glucuronosyltransferase | 3 | 2017 | 38 | 0.230 |
Why?
|
| Apoptosis | 4 | 2008 | 1641 | 0.200 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 13 | 0.190 |
Why?
|
| Organoplatinum Compounds | 1 | 2021 | 21 | 0.190 |
Why?
|
| Leucovorin | 1 | 2021 | 35 | 0.190 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 61 | 0.190 |
Why?
|
| Immunophenotyping | 1 | 2021 | 110 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 41 | 0.190 |
Why?
|
| Fluorouracil | 1 | 2021 | 130 | 0.180 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 14 | 0.170 |
Why?
|
| Integrin beta1 | 1 | 2019 | 48 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 37 | 0.160 |
Why?
|
| Organogenesis | 1 | 2019 | 49 | 0.160 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 498 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 331 | 0.160 |
Why?
|
| Prostatic Neoplasms | 3 | 2010 | 778 | 0.150 |
Why?
|
| NADPH Oxidase 4 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 1745 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 61 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 56 | 0.140 |
Why?
|
| Breast Neoplasms | 5 | 2008 | 1536 | 0.140 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2016 | 28 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2013 | 111 | 0.130 |
Why?
|
| Protein Binding | 2 | 2010 | 1027 | 0.130 |
Why?
|
| Transfection | 3 | 2008 | 782 | 0.130 |
Why?
|
| Cell Movement | 4 | 2014 | 630 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 420 | 0.130 |
Why?
|
| Biomarkers | 1 | 2021 | 1593 | 0.130 |
Why?
|
| Molecular Structure | 2 | 2013 | 397 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 144 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 499 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2013 | 546 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2791 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2005 | 852 | 0.120 |
Why?
|
| Hydrazones | 1 | 2013 | 11 | 0.120 |
Why?
|
| Culture Media | 1 | 2013 | 155 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 328 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 100 | 0.110 |
Why?
|
| Male | 5 | 2017 | 37321 | 0.110 |
Why?
|
| Doxorubicin | 2 | 2005 | 231 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2013 | 489 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2013 | 305 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 100 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 507 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2016 | 447 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2673 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 411 | 0.100 |
Why?
|
| Female | 7 | 2017 | 38074 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 215 | 0.090 |
Why?
|
| Drug Resistance, Multiple | 2 | 2008 | 56 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 370 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2010 | 369 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2016 | 1200 | 0.090 |
Why?
|
| beta Catenin | 2 | 2008 | 73 | 0.090 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 32 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 306 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2550 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1664 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 30 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 160 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2013 | 902 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.080 |
Why?
|
| Models, Biological | 2 | 2010 | 981 | 0.080 |
Why?
|
| Integrases | 1 | 2008 | 31 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 954 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 173 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2008 | 312 | 0.070 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2006 | 8 | 0.070 |
Why?
|
| Ductus Arteriosus | 1 | 2006 | 13 | 0.070 |
Why?
|
| Disease Progression | 2 | 2008 | 1038 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 282 | 0.070 |
Why?
|
| Basigin | 2 | 2004 | 53 | 0.070 |
Why?
|
| Gene Expression | 1 | 2009 | 770 | 0.070 |
Why?
|
| Integrins | 2 | 2019 | 115 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 791 | 0.070 |
Why?
|
| Cell Line | 1 | 2010 | 1752 | 0.070 |
Why?
|
| Brevican | 1 | 2005 | 2 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2005 | 36 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 39 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 38 | 0.060 |
Why?
|
| Epithelium | 1 | 2005 | 172 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 73 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 290 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 63 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2019 | 384 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2003 | 295 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2003 | 238 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 508 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2014 | 324 | 0.040 |
Why?
|
| Mesoderm | 1 | 2019 | 231 | 0.040 |
Why?
|
| A549 Cells | 1 | 2016 | 50 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 85 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 185 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 124 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 213 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 284 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2014 | 27 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2013 | 42 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 128 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2014 | 379 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 235 | 0.030 |
Why?
|
| Zebrafish | 1 | 2013 | 187 | 0.030 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2006 | 12 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 62 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 117 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 93 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 562 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2005 | 159 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 108 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 490 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 237 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2005 | 235 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2005 | 176 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 541 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2002 | 19 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 22 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 35 | 0.010 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2002 | 20 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 1692 | 0.010 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2002 | 44 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2002 | 94 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 194 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 233 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2002 | 108 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 194 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2002 | 597 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 5300 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 700 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 753 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 1173 | 0.010 |
Why?
|